Relapsing Pneumonitis Due to Two Distinct Inhibitors of the MAPK/ERK Pathway: Report of a Case

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1754-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

The ERK MAPK Pathway in Bone and Cartilage Formation

2012English

A Rare Case of Hypersensitivity Pneumonitis Due to Florida Red Tide

Case Reports in Pulmonology
2019English

Relapsing Malaria: A Case Report of Primaquine Resistance

Case Reports in Infectious Diseases
2018English

TNFα Induces Survival Through the FLIP-L-dependent Activation of the MAPK/ERK Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

LINC00978 Promotes Hepatocellular Carcinoma Carcinogenesis Partly via Activating the MAPK/ERK Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Inhibition of MAPK/ERK Pathway Promotes Oligodendrocytes Generation and Recovery of Demyelinating Diseases

GLIA
Molecular NeuroscienceNeurologyCellular
2019English

PEA15 Promotes Liver Metastasis of Colorectal Cancer by Upregulating the ERK/MAPK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Erlotinib-Associated Acute Pneumonitis: Report of Two Cases

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy